PQR-626 | Interleukin Related interleukin-related.com

Product Name :
PQR-626

Search keywords :
PQR626

drugId :
null

Target Vo:
mTOR Complex 2

Target Vo Short Name :
mTORC2

Moa_Name:
mTOR Complex 2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Piqur Therapeutics Ag

Active Company_Name :
Piqur Therapeutics Ag

Active Indication_Name:
Tuberous Sclerosis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
NMDAR1 Antibody
STAT1 Antibody (YA059)
Phospho-MLKL (Ser345) Antibody: Phospho-MLKL (Ser345) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to Phospho-MLKL (S345). It can be used for WB,IHC-P assays with tag free, in the background of Mouse.

Author: Interleukin Related

Related Posts